Keyphrases
125I
37%
Alzheimer's Disease
75%
Alzheimer's Disease Brain
19%
Alzheimer's Disease Model
20%
Alzheimer's Disease Pathology
11%
Amyloid beta
16%
Amyloid Deposition
11%
Amyloid Plaques
33%
Amyloid Protein
23%
Amyloid-β Peptide
25%
Antibody Fragment
8%
Apolipoprotein A-I (ApoA-I)
6%
APPPS1
6%
Blood-brain Barrier
75%
Blood-brain Barrier Disruption
6%
Brain Pharmacokinetics
7%
Cerebral Amyloid Angiopathy
19%
Cerebral Vasculature
12%
Chitosan
6%
Contrast Agent
10%
Deconvolution
7%
Endocytosis
12%
Endothelial Cells
15%
Endothelium
32%
Fluorescein
10%
Gut Microbiota
8%
High-density Lipoprotein Cholesterol (HDL-C)
8%
Hippocampal Neurons
7%
Insulin
26%
Insulin Receptor
6%
Insulin Signaling
13%
Intraneuronal
14%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
8%
Melatonin
13%
Mimetic Peptide
8%
Monoclonal Antibody
6%
Nanovehicles
17%
Neurodegeneration
13%
Neurodegenerative Diseases
8%
Neuronal Cells
7%
Neuronal Uptake
8%
Olfactory mucosa
10%
P-glycoprotein (P-gp)
6%
Plaque
13%
Plaque Targeting
8%
Plasma Pharmacokinetics
9%
Polyamines
6%
Scopolamine
9%
Single-photon Emission Computed Tomography (SPECT)
8%
Transdermal Drug Delivery
8%
Neuroscience
Alzheimer's Disease
100%
Amino Terminal Sequence
6%
Amyloid Beta Protein
9%
Amyloid Protein
84%
Apolipoprotein A
6%
Beta Amyloid
15%
Blood Brain Barrier
70%
Blood Plasma
25%
Cerebral Amyloid Angiopathy
16%
Computed Tomography
5%
Contrast Medium
11%
Endocytosis
12%
Fluorescein
9%
High-Density Lipoprotein
9%
Histidine
6%
Immunotherapy
5%
In Vitro
10%
In Vivo
9%
Insulin Receptor
7%
Insulin Signaling
14%
Internalization
6%
Iodine-125
34%
Magnetic Resonance Imaging
6%
Molecular Imaging
8%
Monoclonal Antibody
6%
Neurodegeneration
7%
Neurodegenerative Disorder
7%
Pharmacokinetics
22%
Polyamine
6%
Positron Emission Tomography
6%
Putrescine
5%
Synapsin I
5%